《2018年韩国胃癌诊疗指南：基于证据的多学科方法》 - Suppr

Suppr

超能文献

Korean Practice Guideline for Gastric Cancer 2018: an Evidence-based, Multi-disciplinary Approach.

出版信息

J Gastric Cancer. 2019 Mar;19(1):1-48. doi: 10.5230/jgc.2019.19.e8. Epub 2019 Mar 19.

DOI:10.5230/jgc.2019.19.e8

PMID:30944757

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6441770/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/862a/6441770/51b9db0b4abe/jgc-19-1-g001.jpg

相似文献

Korean Practice Guideline for Gastric Cancer 2018: an Evidence-based, Multi-disciplinary Approach.《2018年韩国胃癌诊疗指南：基于证据的多学科方法》

J Gastric Cancer. 2019 Mar;19(1):1-48. doi: 10.5230/jgc.2019.19.e8. Epub 2019 Mar 19.

Erratum: Korean Practice Guideline for Gastric Cancer 2018: an Evidence-based, Multi-disciplinary Approach.勘误：《2018年韩国胃癌诊疗指南：循证多学科方法》

J Gastric Cancer. 2019 Sep;19(3):372-373. doi: 10.5230/jgc.2019.19.e32. Epub 2019 Sep 26.

Korean clinical practice guideline for pancreatic cancer 2021: A summary of evidence-based, multi-disciplinary diagnostic and therapeutic approaches.2021 年韩国胰腺癌临床实践指南：基于循证的多学科诊断和治疗方法概述。

Pancreatology. 2021 Oct;21(7):1326-1341. doi: 10.1016/j.pan.2021.05.004. Epub 2021 May 19.

Korean Practice Guidelines for Gastric Cancer 2024: An Evidence-based, Multidisciplinary Approach (Update of 2022 Guideline).《2024年韩国胃癌诊疗指南：基于证据的多学科方法（2022年指南更新）》

J Gastric Cancer. 2025 Jan;25(1):5-114. doi: 10.5230/jgc.2025.25.e11.

[Clinical practice guideline for multi-disciplinary treatment strategy of lymphoma in China].[中国淋巴瘤多学科诊疗策略临床实践指南]

Zhonghua Zhong Liu Za Zhi. 2021 Feb 23;43(2):163-166. doi: 10.3760/cma.j.cn112152-20201109-00971.

Korean Practice Guidelines for Gastric Cancer 2022: An Evidence-based, Multidisciplinary Approach.《2022年韩国胃癌诊疗指南：基于证据的多学科方法》

J Gastric Cancer. 2023 Jan;23(1):3-106. doi: 10.5230/jgc.2023.23.e11.

[Clinical practice guideline for multi-disciplinary team diagnosis and treatment of stage Ⅳ primary lung cancer in China].《中国Ⅳ期原发性肺癌多学科团队诊疗临床实践指南》

Zhonghua Zhong Liu Za Zhi. 2022 Jul 23;44(7):667-672. doi: 10.3760/cma.j.cn112152-20211221-00959.

[Synopsis on clinical practice guideline of gastric cancer in Korea: an evidence-based approach].[韩国胃癌临床实践指南概要：循证方法]

Korean J Gastroenterol. 2014 Feb;63(2):66-81. doi: 10.4166/kjg.2014.63.2.66.

Real-World Compliance of Surgical Treatment According to the Korean Gastric Cancer Guideline 2018: Evaluation From the Nationwide Survey Data 2019 in Korea.依据《2018年韩国胃癌诊疗指南》的外科治疗真实世界依从性：基于2019年韩国全国性调查数据的评估

J Gastric Cancer. 2023 Oct;23(4):535-548. doi: 10.5230/jgc.2023.23.e32.

Korean Surgical Practice Guideline for Pancreatic Cancer 2022: A summary of evidence-based surgical approaches.《2022年韩国胰腺癌手术实践指南：基于证据的手术方法总结》

Ann Hepatobiliary Pancreat Surg. 2022 Feb 28;26(1):1-16. doi: 10.14701/ahbps.22-009.

引用本文的文献

Hepatic resection improves the prognosis of gastric cancer liver metastasis patients with resected primary lesions.肝切除可改善原发性病灶已切除的胃癌肝转移患者的预后。

Transl Gastroenterol Hepatol. 2025 Jun 3;10:48. doi: 10.21037/tgh-24-126. eCollection 2025.

Patients' Preferences for Gastric Cancer Treatment: A Cross-Sectional Study on Decision-Making in Multidisciplinary Treatment Strategies.胃癌治疗的患者偏好：多学科治疗策略决策的横断面研究

J Gastric Cancer. 2025 Jul;25(3):478-496. doi: 10.5230/jgc.2025.25.e35.

Body composition after treatment of intra-mucosal gastric cancer with endoscopic resection compared to gastrectomy.与胃切除术相比，内镜切除治疗黏膜内胃癌后的身体成分。

Commun Med (Lond). 2025 Jun 13;5(1):231. doi: 10.1038/s43856-025-00931-6.

Laparoscopic gastrectomy reduced peritoneal recurrence in Borrmann type IV gastric cancer: a retrospective cohort study with propensity score matching.腹腔镜胃切除术降低Borrmann IV型胃癌的腹膜复发：一项倾向评分匹配的回顾性队列研究

Surg Endosc. 2025 May 27. doi: 10.1007/s00464-025-11791-5.

Machine Learning Insight: Unveiling Overlooked Risk Factors for Postoperative Complications in Gastric Cancer.机器学习洞察：揭示胃癌术后并发症被忽视的风险因素

Cancers (Basel). 2025 Apr 4;17(7):1225. doi: 10.3390/cancers17071225.

Comparative study of ICG and non-ICG-guided laparoscopic gastrectomy for gastric cancer: a propensity score-matched analysis at a single center.吲哚菁绿（ICG）与非ICG引导的腹腔镜胃癌切除术的比较研究：单中心倾向评分匹配分析

BMJ Surg Interv Health Technol. 2025 Mar 5;7(1):e000313. doi: 10.1136/bmjsit-2024-000313. eCollection 2025.

Immunotherapy or Targeted Therapy Versus Best Supportive Care for Advanced Gastric Cancer: A Systematic Review and Meta-analysis of Randomized Trials.免疫疗法或靶向疗法与晚期胃癌的最佳支持治疗对比：一项随机试验的系统评价和荟萃分析

J Gastrointest Cancer. 2025 Mar 4;56(1):75. doi: 10.1007/s12029-024-01155-y.

Perioperative tislelizumab plus chemotherapy for locally advanced gastroesophageal junction adenocarcinoma (NEOSUMMIT-03): a prospective, nonrandomized, open-label, phase 2 trial.围手术期替雷利珠单抗联合化疗治疗局部晚期胃食管交界腺癌（NEOSUMMIT-03）：一项前瞻性、非随机、开放标签的2期试验。

Signal Transduct Target Ther. 2025 Feb 5;10(1):60. doi: 10.1038/s41392-025-02160-8.

Rare epithelial gastric cancers: a review of the current treatment knowledge.罕见上皮性胃癌：当前治疗知识综述

Ther Adv Med Oncol. 2025 Jan 24;17:17588359241255628. doi: 10.1177/17588359241255628. eCollection 2025.

J Gastric Cancer. 2025 Jan;25(1):5-114. doi: 10.5230/jgc.2025.25.e11.

本文引用的文献

Randomized phase III trial of gastrectomy with or without neoadjuvant S-1 plus cisplatin for type 4 or large type 3 gastric cancer, the short-term safety and surgical results: Japan Clinical Oncology Group Study (JCOG0501).随机 III 期临床试验：胃切除术联合或不联合新辅助 S-1 加顺铂治疗 4 型或大型 3 型胃癌的短期安全性和手术结果：日本临床肿瘤学组研究（JCOG0501）。

Gastric Cancer. 2019 Sep;22(5):1044-1052. doi: 10.1007/s10120-019-00941-z. Epub 2019 Mar 2.

A Phase III Study to Compare the Efficacy and Safety of Paclitaxel Versus Irinotecan in Patients with Metastatic or Recurrent Gastric Cancer Who Failed in First-line Therapy (KCSG ST10-01).一项比较紫杉醇与伊立替康在一线治疗失败的转移性或复发性胃癌患者中的疗效和安全性的 III 期研究（KCSG ST10-01）。

Oncologist. 2019 Jan;24(1):18-e24. doi: 10.1634/theoncologist.2018-0142. Epub 2018 Aug 20.

Endoscopic submucosal dissection for papillary adenocarcinoma of the stomach: low curative resection rate but favorable long-term outcomes after curative resection.内镜黏膜下剥离术治疗胃管状绒毛状腺癌：根治性切除术后的低治愈率，但长期疗效良好。

Gastric Cancer. 2019 Mar;22(2):363-368. doi: 10.1007/s10120-018-0857-3. Epub 2018 Jul 23.

Current status of endoscopic submucosal dissection for early gastric cancer in Korea: role and benefits.韩国早期胃癌内镜黏膜下剥离术的现状：作用和益处。

Korean J Intern Med. 2019 Jul;34(4):785-793. doi: 10.3904/kjim.2017.374. Epub 2018 Jun 21.

Treatment patterns and outcomes in patients with metastatic gastric cancer receiving third-line chemotherapy: A population-based outcomes study.三线化疗治疗转移性胃癌患者的治疗模式和结局：一项基于人群的结局研究。

PLoS One. 2018 Jun 7;13(6):e0198544. doi: 10.1371/journal.pone.0198544. eCollection 2018.

Optimal reconstruction methods after distal gastrectomy for gastric cancer: A systematic review and network meta-analysis.胃癌远端胃切除术后的最佳重建方法：一项系统评价和网状Meta分析

Medicine (Baltimore). 2018 May;97(20):e10823. doi: 10.1097/MD.0000000000010823.

Long-Term Clinical Outcomes of Endoscopic Submucosal Dissection in Patients with Early Gastric Cancer: A Prospective Multicenter Cohort Study.内镜黏膜下剥离术治疗早期胃癌的长期临床疗效：一项前瞻性多中心队列研究。

Gut Liver. 2018 Jul 15;12(4):402-410. doi: 10.5009/gnl17414.

Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2015.韩国癌症统计数据：2015 年发病率、死亡率、生存率和流行率。

Cancer Res Treat. 2018 Apr;50(2):303-316. doi: 10.4143/crt.2018.143. Epub 2018 Mar 21.

Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer: Phase 2 Clinical KEYNOTE-059 Trial.帕博利珠单抗单药治疗既往治疗的晚期胃和胃食管结合部癌患者的安全性和疗效：Ⅱ期 KEYNOTE-059 临床试验。

JAMA Oncol. 2018 May 10;4(5):e180013. doi: 10.1001/jamaoncol.2018.0013.

Meta-analysis of microsatellite instability in relation to clinicopathological characteristics and overall survival in gastric cancer.胃癌中微卫星不稳定性与临床病理特征及总生存关系的荟萃分析。

Br J Surg. 2018 Feb;105(3):159-167. doi: 10.1002/bjs.10663. Epub 2017 Nov 1.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验